Policy and partnerships. Innovation and investment. Access and awareness. Mid-Atlantic Bio: at the epicenter of bioscience R&D, capital and policy.
Mid-Atlantic Bio is the premier regional biotech conference for senior-level executives, policymakers, academia, financiers, media and service providers. First launched in 2005, the conference is a joint initiative of the founding host organizations: the Mid-Atlantic Venture Association, the Virginia Biotechnology Association, and the Technology Council of Maryland. The Conference is also pleased to welcome the North Carolina Biotechnology Center as a Strategic Partner for 2012.
Drawing attendance from leading industry clusters and centers of excellence – both in and outside the region’s footprint – the 2012 Mid-Atlantic Bio conference will bring together a critical mass of key industry stakeholders and create an ideal forum to impact the business, policy and financial climates so imperative to innovation.
For two days, attendees will engage in policy discussions, educational workshops, partnering and business development meetings, investor presentations, media briefings, and innovation exhibitions.
Whether you need to finance, partner or license technology, Mid-Atlantic Bio introduces you to key decision-makers. Join more than 1,000 industry stakeholders – representing 30 states and 10 countries – for the 2012 Mid-Atlantic Bio Conference, September 27th -28th, in Bethesda, MD.